9.84% 0.00645

Imac Holdings Inc (BACK)

Überblick Nachrichten Preisverlauf Financials Warum fällt BACK? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Imac Holdings Inc Stock (BACK) Company Profile

Imac Holdings Inc

Healthcare (1145)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

BACK's Discussions on Twitter

Vergleichen Sie BACK mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BACK Imac Holdings Inc	0.072	0	57,800	-8.76M	-4.56M	-6.8367
HCA Hca Healthcare Inc	458.06	104.60B	74.37B	7.31B	8.10B	25.88
THC Tenet Healthcare Corp	212.88	18.59B	20.69B	2.40B	1.55B	15.62
FMS Fresenius Medical Care Ag Adr	27.14	15.99B	21.23B	924.30M	2.22B	1.2272
EHC Encompass Health Corp	126.61	12.70B	5.51B	494.70M	386.40M	4.84
UHS Universal Health Services Inc	211.65	13.41B	16.08B	1.20B	1.06B	17.82

Imac Holdings Inc Aktie (BACK) Neueste Nachrichten

Finanzdaten der Imac Holdings Inc-Aktie (BACK)

Imac Holdings Inc (BACK)

Imac Holdings Inc Stock (BACK) Company Profile

Vergleichen Sie BACK mit anderen Aktien

Imac Holdings Inc Aktie (BACK) Neueste Nachrichten

IMAC Holdings Issues Unsecured Promissory Note - MSN

IMAC (BACK) raises $144,000 via unsecured $201,600 note - Stock Titan

IMAC Holdings, Inc. announced that it has received $0.144 million in funding - MarketScreener

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IMAC Holdings, Inc. Merger - 富途牛牛

IMAC Holdings, Inc. announced that it has received $0.212 million in funding - MarketScreener

IMAC Holdings Issues Promissory Note Amid Board Changes - TipRanks

Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers - GlobeNewswire

600 Late-Stage Cancer Patients: Ignite Proteomics Launches Groundbreaking Precision Treatment Study - Stock Titan

IMAC Holdings Announces Research Collaboration with - GlobeNewswire

Cancer Research Breakthrough: IMAC-Vanderbilt Alliance Targets New Breast Cancer Treatment Markers - Stock Titan

IMAC Holdings Announces Research Collaboration with Vanderbilt U - GuruFocus

IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery - Yahoo Finance

Delisting of Securities from The Nasdaq Stock Market - The Manila Times

Nasdaq Announces Delisting of Multiple Companies Including NKGen Biotech, Aquaron Acquisition Corp, and Others - Quiver Quantitative

Allarity Therapeutics appoints Jeffrey S. Ervin as part-time chief financial officer - Investing.com Nigeria

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer - The Manila Times

Former NYSE Executive Takes CFO Role at Cancer Drug Developer Allarity Therapeutics - Stock Titan

Imac Holdings Issues Unsecured Promissory Note - TipRanks

Form 10-KAnnual Reports - Stock Titan

Is IMAC Holdings, Inc. overvalued or undervalued? - MarketsMojo

IMAC Holdings Issues Promissory Note for $301,000 - TipRanks

IMAC Holdings Appoints New Board Members for Strategic Growth - TipRanks

IMAC Holdings Issues Promissory Note for $455,000 - TipRanks

HCA Healthcare (HCA) Stock Drops 5% Amid Industry Decline - GuruFocus

IMAC Holdings Delays Q1 2025 Report Filing - TipRanks

IMAC Holdings Issues Promissory Note for $275,800 - TipRanks

United States shares lower at close of trade; Dow Jones Industrial Average down 0.31% - Investing.com India

Local company faces delisting | Area Stocks - Nashville Post

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.31% - Investing.com

US Stocks Mixed; Core & Main Posts Downbeat Earnings - Benzinga

IMAC Holdings delisted from the Nasdaq, looking to listing elsewhere - The Business Journals

Imac Holdings investor Jorge Ruiz sells $15,000 in stock By Investing.com - Investing.com

IMAC Holdings violated another Nasdaq listing rule - The Business Journals

Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference - Yahoo Finance

Ignite Proteomics LLC Completes Transfer of PLA Code 0249U to Enhance Breast Cancer Diagnostic Capabilities - Nasdaq

IMAC Holdings to appeal Nasdaq delisting ruling - The Business Journals

IMAC Holdings Announces Proxy Statement Filing and NASDAQ Appeal - Investing.com

XETRA Trading Companies List - Morningstar

Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response - GlobeNewswire

US Stocks Mixed; General Dynamics Earnings Top Views - Benzinga

Is BACK Making a Comeback? - StocksToTrade

IMAC Holdings Launches Ignite Proteomics to Revolutionize Cancer Treatment Selection with Protein-Level Insights - Quiver Quantitative

IMAC Holdings faces Nasdaq delisting over equity shortfall - Investing.com

IMAC Holdings regains Nasdaq compliance for one of two infractions - The Business Journals

IMAC Holdings regains Nasdaq compliance with audit committee requirements - Investing.com

IMAC Holdings receives another strike from Nasdaq - The Business Journals

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewswire

IMAC lands delisting deadline extension - Nashville Post

IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) - GlobeNewswire

Brookdale Senior Living (BKD) Sees Stock Surge Amid Mixed Analys - GuruFocus

IMAC Holdings welcomes Jeffrey Busch to its Board of Directors - Investing.com

Finanzdaten der Imac Holdings Inc-Aktie (BACK)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie BACK